Literature DB >> 12379704

Phage therapy of local and systemic disease caused by Vibrio vulnificus in iron-dextran-treated mice.

Karen E Cerveny1, Angelo DePaola, Donna H Duckworth, Paul A Gulig.   

Abstract

Vibrio vulnificus is a gram-negative bacterium that contaminates filter-feeding shellfish such as oysters. After ingestion of contaminated oysters, predisposed people may experience highly lethal septicemia. Contamination of wounds with the bacteria can result in devastating necrotizing fasciitis, which can progress to septicemia. The extremely rapid progression of these diseases can render antibiotic treatment ineffective, and death is a frequent outcome. In this study, we examined the potential use of bacteriophages as therapeutic agents against V. vulnificus in an iron-dextran-treated mouse model of V. vulnificus infection. Mice were injected subcutaneously with 10 times the lethal dose of V. vulnificus and injected intravenously, either simultaneously or at various times after infection, with phages. Treatment of mice with phages could prevent death; systemic disease, as measured by CFU per gram of liver and body temperature; and local disease, as measured by CFU per gram of lesion material and histopathologic analysis. Two different phages were effective against three different V. vulnificus strains with various degrees of virulence, while a third phage that required the presence of seawater to lyse bacteria in vitro was ineffective at treating mice. Optimum protection required that the phages be administered within 3 h of bacterial inoculation at doses as high as 10(8) PFU. One of the protective phages had a half-life in blood of over 2 h. These results demonstrate that bacteriophages have therapeutic potential for both localized and systemic infections caused by V. vulnificus in animals. This model should be useful in answering basic questions regarding phage therapy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379704      PMCID: PMC130292          DOI: 10.1128/IAI.70.11.6251-6262.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Pulmonary damage by Vibrio vulnificus cytolysin.

Authors:  J W Park; S N Ma; E S Song; C H Song; M R Chae; B H Park; R W Rho; S D Park; H R Kim
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Vibrio vulnificus infection: an important cause of septicemia in patients with cirrhosis.

Authors:  C M Vollberg; J L Herrera
Journal:  South Med J       Date:  1997-10       Impact factor: 0.954

3.  Pulsed-field gel electrophoresis and ribotype profiles of clinical and environmental Vibrio vulnificus isolates.

Authors:  M L Tamplin; J K Jackson; C Buchrieser; R L Murphree; K M Portier; V Gangar; L G Miller; C W Kaspar
Journal:  Appl Environ Microbiol       Date:  1996-10       Impact factor: 4.792

4.  Role of catechol siderophore synthesis in Vibrio vulnificus virulence.

Authors:  C M Litwin; T W Rayback; J Skinner
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Distribution of Vibrio vulnificus phage in oyster tissues and other estuarine habitats.

Authors:  A DePaola; S McLeroy; G McManus
Journal:  Appl Environ Microbiol       Date:  1997-06       Impact factor: 4.792

6.  The epidemiology of Vibrio infections in Florida, 1981-1993.

Authors:  W G Hlady; K C Klontz
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

7.  Long-circulating bacteriophage as antibacterial agents.

Authors:  C R Merril; B Biswas; R Carlton; N C Jensen; G J Creed; S Zullo; S Adhya
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

8.  Evidence that mortality from Vibrio vulnificus infection results from single strains among heterogeneous populations in shellfish.

Authors:  J K Jackson; R L Murphree; M L Tamplin
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

9.  Influence of water temperature and salinity on Vibrio vulnificus in Northern Gulf and Atlantic Coast oysters (Crassostrea virginica).

Authors:  M L Motes; A DePaola; D W Cook; J E Veazey; J C Hunsucker; W E Garthright; R J Blodgett; S J Chirtel
Journal:  Appl Environ Microbiol       Date:  1998-04       Impact factor: 4.792

10.  Phages infecting Vibrio vulnificus are abundant and diverse in oysters (Crassostrea virginica) collected from the Gulf of Mexico.

Authors:  A DePaola; M L Motes; A M Chan; C A Suttle
Journal:  Appl Environ Microbiol       Date:  1998-01       Impact factor: 4.792

View more
  47 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

Review 2.  Biodiversity of vibrios.

Authors:  Fabiano L Thompson; Tetsuya Iida; Jean Swings
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

3.  Isolation and characterization of Klebsiella pneumoniae specific bacteriophages from sewage samples.

Authors:  S Kumari; K Harjai; S Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2010-06-06       Impact factor: 2.099

4.  Efficacy and pharmacokinetics of bacteriophage therapy in treatment of subclinical Staphylococcus aureus mastitis in lactating dairy cattle.

Authors:  J J Gill; J C Pacan; M E Carson; K E Leslie; M W Griffiths; P M Sabour
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent.

Authors:  Vivek Verma; Kusum Harjai; Sanjay Chhibber
Journal:  Curr Microbiol       Date:  2009-05-30       Impact factor: 2.188

6.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

Authors:  Lisa A Carmody; Jason J Gill; Elizabeth J Summer; Uma S Sajjan; Carlos F Gonzalez; Ryland F Young; John J LiPuma
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

7.  Transfersomal Phage Cocktail Is an Effective Treatment against Methicillin-Resistant Staphylococcus aureus-Mediated Skin and Soft Tissue Infections.

Authors:  Sanjay Chhibber; Ashu Shukla; Sandeep Kaur
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

8.  Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle.

Authors:  Longping Li; Zhiying Zhang
Journal:  Mol Biol Rep       Date:  2014-07-01       Impact factor: 2.316

9.  Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections.

Authors:  Marine Henry; Rob Lavigne; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

10.  Vibrio vulnificus bacteriophage SSP002 as a possible biocontrol agent.

Authors:  Hyun Sung Lee; Slae Choi; Hakdong Shin; Ju-Hoon Lee; Sang Ho Choi
Journal:  Appl Environ Microbiol       Date:  2013-11-08       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.